![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiao Ma, Changhua Mo, Yujuan Li, Xinyuan Chen & Chun Gui. (2023) Prediction of the development of contrast‑induced nephropathy following percutaneous coronary artery intervention by machine learning. Acta Cardiologica 0:0, pages 1-10.
Read now
Read now
Articles from other publishers (79)
Xiao Ma, Changhua Mo, Yujuan Li & Chun Gui. (2023) Systemic immune-inflammation index associated with contrast-induced nephropathy after elective percutaneous coronary intervention in a case-control study. Coronary Artery Disease 34:6, pages 432-440.
Crossref
Crossref
Breda Hennessey, John C. Messenger, Ajay J. Kirtane, Manish Parikh, Haim Danenberg, Frédéric De Vroey, Alejandro Curcio, Peter Eshuis & Javier Escaned. (2023) Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial. American Heart Journal 263, pages 151-158.
Crossref
Crossref
Mehmet Erdoğan, Serkan Bulguroglu, Selçuk Öztürk, Burak Kardeşler, Yunus Çalapkulu, Murat Yigitbası, Murat Akçay & Tahir Durmaz. (2020) Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker to Predict Contrast-Induced Nephropathy After Coronary Angiography. Angiology 74:1, pages 95-96.
Crossref
Crossref
Keita Hirano, Daiki Kobayashi, Takuro Shimbo & Yasuhiro Komatsu. (2022) Impact of a continuous quality improvement program on contrast-induced nephropathy in outpatients with chronic kidney disease: an interrupted time-series study. Nephrology Dialysis Transplantation.
Crossref
Crossref
Winn Cashion & Steven D. Weisbord. (2022) Radiographic Contrast Media and the Kidney. Clinical Journal of the American Society of Nephrology 17:8, pages 1234-1242.
Crossref
Crossref
Euan A. Sandilands, Jessica M. B. Rees, Khuram Raja, Neeraj Dhaun, Emma E. Morrison, Kirsty Hickson, Jonathan Wraight, Tanya Gray, Lesley Briody, Sharon Cameron, Adrian P. Thompson, Neil R. Johnston, Neal Uren, Jane Goddard, Andy Treweeke, Gordon Rushworth, David J. Webb, D. Nicholas Bateman, John Norrie, Ian L. Megson & Michael Eddleston. (2022) Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast‐Induced Nephropathy: A Failure of Academic Clinical Science. Clinical Pharmacology & Therapeutics 111:6, pages 1222-1238.
Crossref
Crossref
Haoming He, Zhebin You, Xueqin Lin, Chen He, Sicheng Zhang, Manqing Luo, Maoqing Lin, Liwei Zhang, Kaiyang Lin & Yansong Guo. (2021) A Comparison Between Two Definitions of Contrast-Associated Acute Kidney Injury for Long-Term Mortality in Elderly and Non-elderly Patients After Elective Percutaneous Coronary Intervention. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Flavio Giuseppe Biccirè, Simone Budassi & Francesco Prati. (2021) The DyeVert System Choice in OCT Guidance of PCI: Is the Game Worth the Candle?. Cardiovascular Revascularization Medicine 30, pages 47-49.
Crossref
Crossref
Adem Sancı, Alkan Oktar, Mehmet I. Gokce, Evren Süer, Omer Gülpinar, Cagatay Gögüs, Sumer Baltacı & Kadir Turkolmez. (2021) Comparison of Microscopic Hematuria Guidelines as Applied in 1018 Patients With Microscopic Hematuria. Urology 154, pages 28-32.
Crossref
Crossref
Daniel E. Rabinowitz, Karis Buford, Andrew M. Wood, Allison Marziliano, Andre Perez-Orozco, Michael A. Diefenbach, Justin Han, Simon J. Hall & Allison Polland. (2021) Incidence of Significant Findings of Microhematuria Workup in Women—What Guidelines Work Best?. Urology 151, pages 19-23.
Crossref
Crossref
Hanchuan Chen, Chen He, Zhebin You, Sicheng Zhang, Haoming He, Xi′nan Chen, Sunying Wang, Kaiyang Lin & Yansong Guo. (2021) Association between urine pH and risk of contrast-associated acute kidney injury among patients after emergency percutaneous coronary intervention: a V-shape relationship?. Clinical and Experimental Nephrology 25:5, pages 554-561.
Crossref
Crossref
Ali O. Malik, Amit Amin, Kevin Kennedy, Mohammed Qintar, Ali Shafiq, Roxana Mehran & John A. Spertus. (2021) Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention. American Heart Journal 234, pages 51-59.
Crossref
Crossref
Neal Yuan, Khalid Latif, Patrick G. Botting, Yaron Elad, Steven M. Bradley, Teryl K. Nuckols, Susan Cheng & Joseph E. Ebinger. (2021) Refining Safe Contrast Limits for Preventing Acute Kidney Injury After Percutaneous Coronary Intervention. Journal of the American Heart Association 10:1.
Crossref
Crossref
Laith Hattar, Jean-Pierre Assaker, Joe Aoun, Lori Lyn Price, Joseph Carrozza & Bertrand L. Jaber. (2021) Revising the Maximal Contrast Dose for Predicting Acute Kidney Injury following Coronary Intervention. American Journal of Nephrology 52:4, pages 328-335.
Crossref
Crossref
Xiaodan Fu, Jing Dong, Hongyan Wang, Dayuan Lou, Xin Li, Jiajie Mei, Zheng Sui, Qian Yang, Nan Niu & Peng Qu. (2021) Association between plasma endothelial microparticles and contrast-induced nephropathy in patients underwent coronary angiography. Medicine 100:28, pages e24004.
Crossref
Crossref
Joseph Walker Keach, Maggie A. Stanislawski, Anna E. Barón, Mary E. Plomondon, Paula Langner, Amit Amin, Heather M. Gilmartin, Stephen Waldo & Thomas M. Maddox. (2020) Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program. BMC Nephrology 21:1.
Crossref
Crossref
Kai-Yang Lin, Han-Chuan Chen, Hui Jiang, Sun-Ying Wang, Hong-Mei Chen, Zhi-Yong Wu, Feng Jiang, Yan-Song Guo & Peng-Li Zhu. (2020) Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention. BMC Nephrology 21:1.
Crossref
Crossref
Jennifer Natha, Pantea Amin Javaher, Denise Kruger, Eleanor Benterud, Winnie Pearson, Zhi Tan, Bryan Ma, Ben D. Tyrrell, Bryan J. Har, Michelle M. Graham & Matthew T. James. (2020) Patient Experience Following Risk Stratification and Follow-up for Acute Kidney Injury After Cardiac Catheterization: Patient Survey. CJC Open.
Crossref
Crossref
Anand Prasad, Ning A. Rosenthal, Alex Kartashov, Kimberly Knish & Jill Dreyfus. (2020) Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures. Catheterization and Cardiovascular Interventions 96:6, pages 1184-1197.
Crossref
Crossref
Zhaodong Guo, Jin Liu, Li Lei, Yan Xue, Liwei Liu, Hao Huang, Shiqun Chen, Yong Liu, Yingzhong Lin, Jianhong Tao, Qingbo Xu, Keng Wu, Lingyu Zhang & Ji-Yan Chen. (2020) Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials. BMJ Open 10:10, pages e039009.
Crossref
Crossref
Yasir Abdul Ghaffar & Ramesh Daggubati. (2020) Nicorandil for CIN Prevention — A Hope or Hype?. Cardiovascular Revascularization Medicine 21:9, pages 1128-1130.
Crossref
Crossref
Daniel E. Rabinowitz, Andrew M. Wood, Allison Marziliano, Andre Perez-Orozco, Andrew Ng, Michael A. Diefenbach, Patrick Samson, Manish A. Vira, Justin Han, Ariel Schulman & Simon J. Hall. (2020) Use of a Risk Stratification Tool to Guide Evaluation of Patients With Asymptomatic Microscopic Hematuria. Urology 141, pages 27.e1-27.e6.
Crossref
Crossref
Ozan M. Demir, Enrico Poletti, Francesca Lombardo, Alessandra Laricchia, Alessandro Beneduce, Davide Maccagni, Alberto Cappelletti, Antonio Colombo, Barbara Bellini, Marco B. Ancona, Mauro Carlino, Alaide Chieffo, Matteo Montorfano & Lorenzo Azzalini. (2020) Rotational atherectomy-based percutaneous coronary intervention and the risk of contrast-induced nephropathy. Minerva Cardioangiologica 68:2.
Crossref
Crossref
Theodosios Bisdas & Stylianos Koutsias. (2020) Carbon Dioxide As a Standard of Care for Zero Contrast Interventions: When, Why and How?. Current Pharmaceutical Design 25:44, pages 4662-4666.
Crossref
Crossref
Viktor I. Óriás, Dávid Szöllősi, Marcell Gyánó, Dániel S. Veres, Sándor Nardai, Csaba Csobay-Novák, Balázs Nemes, János P Kiss, Krisztián Szigeti, Szabolcs Osváth, Péter Sótonyi & Zoltán Ruzsa. (2020) Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions. European Journal of Radiology Open 7, pages 100288.
Crossref
Crossref
Guoqiang Gu, Xuechao Yuan, Yaqing Zhou, Demin Liu & Wei Cui. (2019) Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention. BMC Cardiovascular Disorders 19:1.
Crossref
Crossref
Armin Marashizadeh, Hamid Reza Sanati, Parham Sadeghipour, Mohamad Mehdi Peighambari, Jamal Moosavi, Omid Shafe, Ata Firouzi, Ali Zahedmehr, Mohsen Maadani, Farshad Shakerian, Reza Kiani, Bahram Mohebbi, Mohammad Javad Alemzadeh-Ansari, Reza Tahvili & Batoul Naghavi. (2019) Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial. International Urology and Nephrology 51:10, pages 1815-1822.
Crossref
Crossref
Adam Stys, Maheedhar Gedela, Udit Bhatnagar, Marian Petrasko, Hazem Dawoud, Tadeusz Malinski & Tomasz Stys. (2019) A Prospective Study of Contrast Preservation Using Ultra-Low Contrast Delivery Technique Versus Standard Automated Contrast Injector System in Coronary Procedures. Indian Heart Journal.
Crossref
Crossref
Matthew T. James, Bryan J. Har, Ben D. Tyrrell, Bryan Ma, Peter Faris, Tolulope T. Sajobi, David W. Allen, John A. Spertus, Stephen B. Wilton, Neesh Pannu, Scott W. Klarenbach & Michelle M. Graham. (2019) Clinical Decision Support to Reduce Contrast-Induced Kidney Injury during Cardiac Catheterization: Design of a Randomized Stepped-Wedge Trial. Canadian Journal of Cardiology.
Crossref
Crossref
Emma Healy & Jason H. Wasfy. (2019) Translating Experimental Evidence Into Clinical Decision Making. Cardiovascular Revascularization Medicine 20:1, pages 9-10.
Crossref
Crossref
Ozan M. Demir, Francesca Lombardo, Enrico Poletti, Alessandra Laricchia, Alessandro Beneduce, Davide Maccagni, Massimo Slavich, Francesco Giannini, Mauro Carlino, Alberto Margonato, Alberto Cappelletti, Antonio Colombo & Lorenzo Azzalini. (2018) Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease. The American Journal of Cardiology 122:11, pages 1837-1842.
Crossref
Crossref
Kai-Yang Lin, Xiu-Ling Shang, Yan-Song Guo, Peng-Li Zhu, Zhi-Yong Wu, Hui Jiang, Jing-Ming Ruan, Wei-Ping Zheng, Zhe-Bin You & Chun-Jin Lin. (2018) Association of Preprocedural Hyperglycemia With Contrast-Induced Acute Kidney Injury and Poor Outcomes After Emergency Percutaneous Coronary Intervention. Angiology 69:9, pages 770-778.
Crossref
Crossref
Eric A. J. Hoste, John A. Kellum, Nicholas M. Selby, Alexander Zarbock, Paul M. Palevsky, Sean M. Bagshaw, Stuart L. Goldstein, Jorge Cerdá & Lakhmir S. Chawla. (2018) Global epidemiology and outcomes of acute kidney injury. Nature Reviews Nephrology 14:10, pages 607-625.
Crossref
Crossref
Kai-yang Lin, Zhi-yong Wu, Zhe-bin You, Wei-ping Zheng, Chun-jin Lin, Hui Jiang, Jing-ming Ruan, Yan-song Guo & Peng-li Zhu. (2018) Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention. International Heart Journal 59:5, pages 926-934.
Crossref
Crossref
Swapnil Hiremath, Ayub Akbari, George A. Wells & Benjamin J. W. Chow. (2018) Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis. International Urology and Nephrology 50:8, pages 1477-1482.
Crossref
Crossref
Margarita Braunagel, Florian Ortner, Ulf Schönermarck, Antje Habicht, Andreas Schindler, Manfred Stangl, Frederik F. Strobl, Maximilian Reiser, Dirk A. Clevert, Christoph Trumm & Andreas Helck. (2018) Dynamic CTA in Native Kidneys Using a Multiphase CT Protocol—Potential of Significant Reduction of Contrast Medium. Academic Radiology 25:7, pages 842-849.
Crossref
Crossref
Steven D. WeisbordMartin GallagherHani JneidSantiago GarciaAlan CassSoe-Soe ThwinTodd A. ConnerGlenn M. ChertowDeepak L. Bhatt, Kendrick ShunkChirag R. ParikhEdward O. McFallsMary BrophyRyan FergusonHongsheng WuMaria AndrosenkoJohn MylesJames KaufmanPaul M. Palevsky. (2018) Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. New England Journal of Medicine 378:7, pages 603-614.
Crossref
Crossref
S.D. Weisbord & P.M. Palevsky. 2018. Comprehensive Toxicology. Comprehensive Toxicology
274
303
.
Steven D. Weisbord. 2018. Core Concepts in Acute Kidney Injury. Core Concepts in Acute Kidney Injury
95
112
.
Eleni Palli, Demosthenes Makris, John Papanikolaou, Grigorios Garoufalis, Irini Tsilioni, Paris Zygoulis & Epaminondas Zakynthinos. (2017) The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study. Critical Care 21:1.
Crossref
Crossref
James Sapontis, Garry Barron, Sujith Seneviratne, Georg Fuernau, Ingo Eitel, Jakob Ledwoch, Holger Thiele, Mohammed Saad, Suzanne de Waha, Janine Poess & Steffen Desch. (2017) A first in human evaluation of a novel contrast media saving device. Catheterization and Cardiovascular Interventions 90:6, pages 928-934.
Crossref
Crossref
Lorenzo Azzalini, Luciano Candilio, Peter A. McCullough & Antonio Colombo. (2017) Current Risk of Contrast-Induced Acute Kidney Injury Following Coronary Angiography and Intervention: A Reappraisal of the Literature. Canadian Journal of Cardiology.
Crossref
Crossref
P. Michael Grossman, Syed S. Ali, Herbert D. Aronow, Michael Boros, Timothy J. Nypaver, Theodore L. Schreiber, Yeo Jung Park, Peter K. Henke & Hitinder S. Gurm. (2017) Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Journal of Interventional Cardiology 30:3, pages 274-280.
Crossref
Crossref
Sahar A. Khaleel, Amany A. Alzokaky, Nahed A. Raslan, Asmaa I. Alwakeel, Heba G. Abd El-Aziz & Adel R. Abd-Allah. (2017) Lansoprazole halts contrast induced nephropathy through activation of Nrf2 pathway in rats. Chemico-Biological Interactions 270, pages 33-40.
Crossref
Crossref
Lorenzo Azzalini & Xavier Garcia-Moll. (2017) On Contrast-Induced Acute Kidney Injury, Risk Prediction, and the Future of Predictive Model Development. Canadian Journal of Cardiology.
Crossref
Crossref
Michael Donahue & Carlo Briguori. 2017. Interventional Cardiology. Interventional Cardiology
274
281
.
Pierre Aubry, Georges Brillet, Laura Catella, Aurélie Schmidt & Stève Bénard. (2016) Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures. BMC Nephrology 17:1.
Crossref
Crossref
Haixia Li, Cailian Wang, Chuanzhi Liu, Ruifei Li, Meijuan Zou & Gang Cheng. (2016) Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials. American Journal of Cardiovascular Drugs 16:3, pages 201-219.
Crossref
Crossref
Marco Di Serafino, Rosa Severino, Carmen Scavone, Matilde Gioioso, Valeria Coppola, Raffaela Brigida, Francesco Lisanti, Rosario Rocca & Enrico Scarano. (2016) Prevention Strategies of Contrast Medium Induced Nephropathy (CIN): A Review of the Current Literature. Open Journal of Nephrology 06:03, pages 98-110.
Crossref
Crossref
Maciej T. Wybraniec & Katarzyna Mizia-Stec. (2016) Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury. Cardiorenal Medicine 6:1, pages 25-36.
Crossref
Crossref
M-Altaf Khan & Vecihi Batuman. 2016. Pituitary Adenylate Cyclase Activating Polypeptide — PACAP. Pituitary Adenylate Cyclase Activating Polypeptide — PACAP
289
312
.
Hiremath Swapnil, Greg A Knoll, Jeanne Françoise Kayibanda, Dean Fergusson, Benjamin JW Chow, Wael Shabana, Erin Murphy, Tim Ramsay, Matthew James, Christine A White, Amit Garg, Ron Wald, Jeffrey Hoch & Ayub Akbari. (2015) Oral Salt and Water versus Intravenous Saline for the Prevention of Acute Kidney Injury following Contrast-Enhanced Computed Tomography: Study Protocol for a Pilot Randomized Trial. Canadian Journal of Kidney Health and Disease 2, pages 48.
Crossref
Crossref
Anthony C. Chyou, Anay Thodge, Dmitriy N. Feldman & Rajesh V. Swaminathan. (2015) Statins in the Prevention of Contrast-Induced Nephropathy. Current Treatment Options in Cardiovascular Medicine 17:4.
Crossref
Crossref
Jeanne Françoise Kayibanda, Swapnil Hiremath, Greg A Knoll, Dean Fergusson, Benjamin JW Chow, Wael Shabana & Ayub Akbari. (2014) Does intravenous contrast-enhanced computed tomography cause acute kidney injury? Protocol of a systematic review of the evidence. Systematic Reviews 3:1.
Crossref
Crossref
Giuseppe AndòCesare de GregorioGaetano MorabitoOlimpia TrioFrancesco SaporitoGiuseppe Oreto. (2014) Renal Function–Adjusted Contrast Volume Redefines the Baseline Estimation of Contrast-Induced Acute Kidney Injury Risk in Patients Undergoing Primary Percutaneous Coronary Intervention. Circulation: Cardiovascular Interventions 7:4, pages 465-472.
Crossref
Crossref
Daisuke Abe, Akira Sato, Tomoya Hoshi, Yuki Kakefuda, Hiroaki Watabe, Eiji Ojima, Daigo Hiraya, Tomohiko Harunari, Noriyuki Takeyasu & Kazutaka Aonuma. (2014) Clinical Predictors of Contrast-Induced Acute Kidney Injury in Patients Undergoing Emergency Versus Elective Percutaneous Coronary Intervention. Circulation Journal, pages 85-91.
Crossref
Crossref
Chao-Fu Chang & Chih-Ching Lin. (2013) Current concepts of contrast-induced nephropathy: A brief review. Journal of the Chinese Medical Association 76:12, pages 673-681.
Crossref
Crossref
Giuseppe Andò, Gaetano Morabito, Cesare de Gregorio, Olimpia Trio, Francesco Saporito & Giuseppe Oreto. (2013) Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 82:6, pages 878-885.
Crossref
Crossref
Gabriela EspinosaAnanth Annapragada. (2013) Cost-Effectiveness of a Novel Blood-Pool Contrast Agent in the Setting of Chest Pain Evaluation in an Emergency Department. American Journal of Roentgenology 201:4, pages 710-719.
Crossref
Crossref
Giuseppe Andò, Gaetano Morabito, Cesare de Gregorio, Olimpia Trio, Francesco Saporito & Giuseppe Oreto. (2013) The ACEF score as predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention. International Journal of Cardiology 168:4, pages 4386-4387.
Crossref
Crossref
J. J. Keaney, C. M. Hannon & P. T. Murray. (2013) Contrast-induced acute kidney injury: how much contrast is safe?. Nephrology Dialysis Transplantation 28:6, pages 1376-1383.
Crossref
Crossref
Eric K. Judd, Shikha Mehta & Ashita J. Tolwani. 2013. Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation. Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation
199
236
.
J. Richenberg. (2012) How to reduce nephropathy following contrast-enhanced CT: A lesson in policy implementation. Clinical Radiology 67:12, pages 1136-1145.
Crossref
Crossref
Santiago Garcia, Byungsoo Ko & Selcuk Adabag. (2012) Contrast-Induced Nephropathy and Risk of Acute Kidney Injury and Mortality After Cardiac Operations. The Annals of Thoracic Surgery 94:3, pages 772-776.
Crossref
Crossref
AJin Cho, Jung Eun Lee, Jae Young Yoon, Hye Ryoun Jang, Wooseong Huh, Yoon-Goo Kim, Dae Joong Kim & Ha Young Oh. (2012) Effect of an Electronic Alert on Risk of Contrast-Induced Acute Kidney Injury in Hospitalized Patients Undergoing Computed Tomography. American Journal of Kidney Diseases 60:1, pages 74-81.
Crossref
Crossref
Liliana Alejandra Chicaíza-Becerra, Mario García-Molina & Óscar Gamboa. (2012) Costo-efectividad de medios de contraste isoosmolales e hiposmolales en pacientes con alto riesgo de nefropatía inducida por medio de contraste. Biomédica 32:2.
Crossref
Crossref
Corinne E. A. Balemans, Louis J. M. Reichert, Bert I. H. van Schelven, Jan A. J. G. van den Brand & Jack F. M. Wetzels. (2012) Epidemiology of Contrast Material–induced Nephropathy in the Era of Hydration. Radiology 263:3, pages 706-713.
Crossref
Crossref
Anupama Kaul. (2012) Contrast-induced acute kidney injury. Clinical Queries: Nephrology 1:1, pages 34-41.
Crossref
Crossref
Hitinder S. Gurm, Simon R. Dixon, Dean E. Smith, David Share, Thomas LaLonde, Adam Greenbaum & Mauro Moscucci. (2011) Renal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions. Journal of the American College of Cardiology 58:9, pages 907-914.
Crossref
Crossref
Oliva C. Fernández-Cimadevilla, Vicente Barriales-Alvarez & Iñigo Lozano-Martínez Luengas. (2011) Nefropatía inducida por contraste. Medicina Clínica 137:2, pages 84-90.
Crossref
Crossref
Steven D. Weisbord & Paul M. Palevsky. (2011) Contrast-Induced Acute Kidney Injury: Short- and Long-Term Implications. Seminars in Nephrology 31:3, pages 300-309.
Crossref
Crossref
L Ren, J Ji, Y Fang, SH Jiang, YM Lin, J Bo, JY Qian, XH Xu & XQ Ding. (2011)
Assessment of Urinary
N
-Acetyl-β-Glucosaminidase as an Early Marker of Contrast-Induced Nephropathy
. Journal of International Medical Research 39:2, pages 647-653.
Crossref
Crossref
Steven D Weisbord & Paul M Palevsky. (2010) Strategies for the prevention of contrast-induced acute kidney injury. Current Opinion in Nephrology and Hypertension 19:6, pages 539-549.
Crossref
Crossref
Joshua M. Stolker, Peter A. McCullough, Seshu Rao, Silvio E. Inzucchi, John A. Spertus, Thomas M. Maddox, Frederick A. Masoudi, Lan Xiao & Mikhail Kosiborod. (2010) Pre-Procedural Glucose Levels and the Risk for Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography. Journal of the American College of Cardiology 55:14, pages 1433-1440.
Crossref
Crossref
PRAVEEN KANDULA, RAVISH SHAH, NISHITH SINGH, STEPHEN J MARKWELL, NISHANT BHENSDADIA & SANKAR D NAVANEETHAN. (2010) Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention. Nephrology 15:2, pages 165-170.
Crossref
Crossref
B. Faurie. (2009) Voie radiale et insuffisance rénale. Annales de Cardiologie et d'Angéiologie 58:6, pages 348-354.
Crossref
Crossref
Po-Tsang Lee, Kang-Ju Chou & Hua-Chang Fang. (2009) Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography. Current Treatment Options in Cardiovascular Medicine 11:1, pages 71-78.
Crossref
Crossref
Peter A. McCullough. (2008) Acute kidney injury with iodinated contrast. Critical Care Medicine 36:Suppl, pages S204-S211.
Crossref
Crossref
Peter A. McCullough. (2008) Contrast-Induced Acute Kidney Injury. Journal of the American College of Cardiology 51:15, pages 1419-1428.
Crossref
Crossref